atomoxetine
- Product NDC
- 70518-2474
- Requested package NDC
- 70518-2474-0
- 11-digit product format
- 705182474
- Labeler code
- 70518
- Product ID
- 70518-2474_c9605376-7e12-58ff-e053-2a95a90a3c51
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- atomoxetine
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- REMEDYREPACK INC.
- Application
- ANDA079019
- Marketing category
- ANDA
- Marketing start
- 2019-12-09
- Marketing end
- 0000-00-00
- Substance
- ATOMOXETINE HYDROCHLORIDE
- Active strength
- 40 mg/1
- Pharmacologic classes
- Norepinephrine Reuptake Inhibitor [EPC],Norepinephrine Uptake Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
Explicit status records from FDA unfinished, excluded, and compounder auxiliary files. Absence of a row is not itself a regulatory status. Browse every current auxiliary row, including rows without a usable NDC. · Browse every captured source and parsed snapshot.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 70518-2474 | 70518-2474-0 | D | Discontinued by firm | 2026-07-31 |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A079019-001 | ATOMOXETINE HYDROCHLORIDE | ATOMOXETINE HYDROCHLORIDE | EQ 10MG BASE | CAPSULE / ORAL | AB | 2017-05-30 | |
| A079019-002 | ATOMOXETINE HYDROCHLORIDE | ATOMOXETINE HYDROCHLORIDE | EQ 18MG BASE | CAPSULE / ORAL | AB | 2017-05-30 | |
| A079019-003 | ATOMOXETINE HYDROCHLORIDE | ATOMOXETINE HYDROCHLORIDE | EQ 25MG BASE | CAPSULE / ORAL | AB | 2017-05-30 | |
| A079019-004 | ATOMOXETINE HYDROCHLORIDE | ATOMOXETINE HYDROCHLORIDE | EQ 40MG BASE | CAPSULE / ORAL | AB | 2017-05-30 | |
| A079019-005 | ATOMOXETINE HYDROCHLORIDE | ATOMOXETINE HYDROCHLORIDE | EQ 60MG BASE | CAPSULE / ORAL | AB | 2017-05-30 | |
| A079019-006 | ATOMOXETINE HYDROCHLORIDE | ATOMOXETINE HYDROCHLORIDE | EQ 80MG BASE | CAPSULE / ORAL | AB | 2017-05-30 | |
| A079019-007 | ATOMOXETINE HYDROCHLORIDE | ATOMOXETINE HYDROCHLORIDE | EQ 100MG BASE | CAPSULE / ORAL | AB | 2017-05-30 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A079019-001 | AB |
| A079019-002 | AB |
| A079019-003 | AB |
| A079019-004 | AB |
| A079019-005 | AB |
| A079019-006 | AB |
| A079019-007 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A079019-001 | ATOMOXETINE HYDROCHLORIDE | EQ 10MG BASE | CAPSULE / ORAL | AB | 2017-05-30 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A079019-002 | ATOMOXETINE HYDROCHLORIDE | EQ 18MG BASE | CAPSULE / ORAL | AB | 2017-05-30 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A079019-003 | ATOMOXETINE HYDROCHLORIDE | EQ 25MG BASE | CAPSULE / ORAL | AB | 2017-05-30 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A079019-004 | ATOMOXETINE HYDROCHLORIDE | EQ 40MG BASE | CAPSULE / ORAL | AB | 2017-05-30 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A079019-005 | ATOMOXETINE HYDROCHLORIDE | EQ 60MG BASE | CAPSULE / ORAL | AB | 2017-05-30 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A079019-006 | ATOMOXETINE HYDROCHLORIDE | EQ 80MG BASE | CAPSULE / ORAL | AB | 2017-05-30 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A079019-007 | ATOMOXETINE HYDROCHLORIDE | EQ 100MG BASE | CAPSULE / ORAL | AB | 2017-05-30 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A079019-001 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A079019-002 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A079019-003 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A079019-004 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A079019-005 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A079019-006 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A079019-007 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| atomoxetine | ATOMOXETINE | Bryant Ranch Prepack | 97a4aa63-0877-40e5-94c4-ea487db5691d | 2026-05-13 | Boxed warning, Warnings, Adverse reactions | 079019 ANDA079019 |
| atomoxetine | ATOMOXETINE | A-S Medication Solutions | 90f45a1e-f79f-468f-b21b-5dc82f5717aa | 2026-05-11 | Boxed warning, Warnings, Adverse reactions | 079019 ANDA079019 |
| atomoxetine | ATOMOXETINE | Northstar Rx LLC | 133a4b65-762b-4712-baba-2442546f0379 | 2026-05-06 | Boxed warning, Warnings, Adverse reactions | 079019 ANDA079019 |
| atomoxetine | ATOMOXETINE | Glenmark Pharmaceuticals Inc., USA | 0ab8d905-e890-4e91-a730-3e5d12f5c23f | 2026-01-07 | Boxed warning, Warnings, Adverse reactions | 079019 ANDA079019 |
| atomoxetine | ATOMOXETINE | A-S Medication Solutions | f75bc8e2-8e8e-4883-be9c-b716842c5277 | 2024-11-21 | Boxed warning, Warnings, Adverse reactions | 079019 ANDA079019 |
| atomoxetine | ATOMOXETINE | A-S Medication Solutions | 793928fb-fbcb-4fc6-90d4-f8a15e6b1f93 | 2024-10-25 | Boxed warning, Warnings, Adverse reactions | 079019 ANDA079019 |
| atomoxetine | ATOMOXETINE | A-S Medication Solutions | 47f6faeb-52b5-4b04-bf34-de5db8eb46dc | 2024-10-21 | Boxed warning, Warnings, Adverse reactions | 079019 ANDA079019 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 70518-2474-0 | 70518247400 | 30 POUCH in 1 BOX (70518-2474-0) > 1 CAPSULE in 1 POUCH (70518-2474-1) | 30 pouch | 2019-12-09 | 0000-00-00 | No | No | Current |